Pneumococcal polysaccharide vaccine (23-valent) vs Belimumab

Interacting Drugs
Pneumococcal polysaccharide vaccine (23-valent)
vs
Belimumab
Security Level
Moderate, Consider therapy modification
Mechanism
Belimumab: May diminish the therapeutic effect of Vaccines (Inactivated).
Management
Consider therapy modification

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Pneumococcal polysaccharide vaccine (23-valent) vs Belimumab